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Migraine affects the female sex to a greater extent than the
male, with a female:male ratio of 3:1. Hormonal fluctua-
tions during the reproductive life may influence migraine
occurrence and intensity, both in a positive or negative
way. Many women experience migraine approaching
menopause, but the trend of migraine symptoms may vary
according to the different stages of the perimenopause. If
a woman is already a migraineur subject, the attacks often
worsen during both the early and late phases of menopau-
sal transition, whereas an onset of migraine is quite rare
[1]. According to some authors, women with premenstrual
syndrome (PMS) before menopause have an increased
prevalence of migraine in late menopausal transition, and
a subsequent reduction of the attacks in postmenopause
[2]. The presence of PMS can be considered one of
the predictors of migraine trend during the menopausal
transition, since women with PMS are more sensitive
to hormonal fluctuations and more prone to develop
moderate to severe menopausal symptoms [3]. Hormone
replacement therapy (HRT) can be used during the
late premenopausal phase and the first years of postmeno-
pause in order to counteract climacteric symptoms [4].
The effect of HRT on migraine has been investigated,
either in its role of provoking or preventing the attacks.
HRT should be administered continuously, without inter-
vals, to avoid sudden estrogen deprivation and the conse-
quent possible onset of migraine [5]. Treatment with
estradiol-based gels and transdermal patches is preferable
to oral formulation as it maintains constant serum hor-
mone levels. In contrast to guidelines on the use of estro-
progestinic contraceptives, migraine with aura is not an
absolute contraindication to HRT when the way of admin-
istration is topical with a low dose of natural estrogens. If
the aura recurs or worsens, HRT should be in any case
discontinued [6]. When the effect of tibolone versus con-
tinuous combined HRT regimen in migraine is compared,
a significant reduction in the hours with pain-limiting
daily activities and of the amount of analgesics intake can
be observed, even if there is no reduction of the days with
migraine [7]. Natural menopause is associated with a
lower incidence of migraine as compared with surgical
menopause [8]; data on migraine prevalence in relation to
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